Quick Summary
Additional Context
Providence Medical Technology has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CORUS Posterior Cervical Stabilization System 3D-T (CORUS PCSS 3D-T), a next-generation version of its posterior cervical fusion (PCF) implant produced in porous titanium through additive manufacturing (AM). Surgeons in California and Virginia have since completed the first commercial procedures with the device.
A Porous Lattice Built Through AM
The device is indicated to stabilize spinal segments as a supplement to PCF in patients with cervical degenerative disc disease and is placed on both sides of the spine through a posterior surgical approach.
It retains the core design of the earlier CORUS PCSS and adds a proprietary titanium lattice modeled on cancellous bone, the